Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1469953

GRB7-mediated enhancement of cell malignant characteristics induced by Helicobacter pylori infection

Provisionally accepted
Xiaofei Ji Xiaofei Ji 1*Huilin Zhao Huilin Zhao 1Si Chen Si Chen 1Xinfeng Bai Xinfeng Bai 2Jianhui Zhang Jianhui Zhang 1Shuzhen Liu Shuzhen Liu 1Zekun Sun Zekun Sun 1Xinying Cao Xinying Cao 1Jianping Wang Jianping Wang 2Ying Zhang Ying Zhang 1Boqing Li Boqing Li 1
  • 1 Other
  • 2 Shandong Provincial Third Hospital, Jinan, Shandong Province, China

The final, formatted version of the article will be published soon.

    Growth factor receptor bound protein 7 (GRB7) is reportedly upregulated in human gastric cancer (GC), which is closely associated with tumor progression and prognosis. However, the mechanism underlying its dysregulation in GC remains poorly understood. In this study, we found that GRB7 overexpression was associated with Helicobacter pylori (H. pylori) infection. GC cells (AGS and MGC-803) infection assays revealed that this upregulation was mediated by the transcription factor STAT3, and activation of STAT3 by H. pylori promoted GRB7 expression in infected GC cells. Moreover, CagA, the key virulence factor of H. pylori, was found involved in STAT3-mediated GRB7 overexpression. The overexpressed GRB7 further promoted GC cell proliferation, migration, and invasion by activating ERK signaling. Mice infection was further used to investigate the action of GRB7. In H. pylori infection, GRB7 expression in mice gastric mucosa was elevated, and higher STAT3 and ERK activation were also detected. These results revealed GRB7-mediated pathogenesis in H. pylori infection, in which H. pylori activates STAT3, leading to increased GRB7 expression, then promotes activation of the ERK signal, and finally enhances malignant properties of infected cells. Our findings elucidate the role of GRB7 in H. pylori-induced gastric disorders, offering new prospects for the treatment and prevention of H. pylori-associated gastric carcinogenesis by targeting GRB7.

    Keywords: Helicobacter pylori, Grb7, gastric cancer, stat3, CagA

    Received: 24 Jul 2024; Accepted: 09 Sep 2024.

    Copyright: © 2024 Ji, Zhao, Chen, Bai, Zhang, Liu, Sun, Cao, Wang, Zhang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.